Total Hip ReplacementDRESS-XNCT07471243
Dressing-related Experiences and Surgical Site Self-care in Hip and Knee Replacement: an Observational Cohort Study
An observational study of Total Hip Replacement and Total Knee Replacement, run by Bournemouth University at 2 sites in United Kingdom.
Trial summary
The goal of this prospective observational cohort study is to investigate dressing-related experiences and surgical site self-care in patients who are undergoing a total hip or knee replacement. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Total Hip Replacement, Total Knee Replacement
- What is being tested?
- Wound Dressing Material
- How many people
- 100 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 23 Jul 2026to 31 Aug 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients undergoing primary total hip or knee replacement at the Nuffield Health Hospital
Who may be able to join
- Adults (18+) undergoing primary total hip or knee replacement
- Enrolled in an ERAS protocol
- Willing and able to provide informed consent
Who cannot join
- Requiring revision replacement
- Unable to provide informed consent (cognitive disorder such as dementia, psychiatric illness)
- Unable to understand written English
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom2 sites, 2 recruiting
- Recruiting
Nuffield Health Hospital Bournemouth
Bournemouth, Dorset, BH1 1RW
Robert Middleton
Robert Middleton
- Not yet recruiting
Bournemouth University
Bournemouth, Dorset, BH8 8EB
Thomas Wainwright, +441202 961656, twainwright@bournemouth.ac.uk
Thomas Wainwright
About this study
Official title: Dressing-Related Experiences and Surgical Site Self-Care in Hip and Knee Replacement: an Observational Cohort Study (DRESS-X)
The goal of this prospective observational cohort study is to investigate dressing-related experiences and surgical site self-care in patients who are undergoing a total hip or knee replacement. The main objectives of the study are:
- To evaluate patient adherence to the ISWCAP self-care checklist after total hip or knee replacement within an ERAS pathway.
- To explore patient-reported outcomes related to the performance and comfort of advanced dressings.
- To assess the perceived adequacy and usefulness of post-discharge wound care education.
- To identify the incidence and types of wound-related complications in the 12 weeks following surgery.
Participants will give informed consent before surgery and will start the study once the dressing has been applied following surgery. There will be follow up study visits at discharge, 7 days, 12 days, 6 weeks and 12 weeks post-surgery. Data relating to vital signs, medical history, surgery and medication will be taken from routine data.
- Conditions
- Total Hip Replacement, Total Knee Replacement
- Being tested
- Wound Dressing Material
- Keywords
- Hip arthroplasty, Hip replacement, Knee arthroplasty, Knee replacement, Musculoskeletal, Enhanced recovery after surgery, ERAS, Surgical wound
- Medical subject headings
- Surgical Wound
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Wound Dressing MaterialOther
The study will investigate any wound dressing applied as part of routine care. Advanced wound dressings are highly absorbent, flexible and comfortable for surgical wounds, and offer up to 14 days wear time. The adhesive moulds to the skin without sticking to the wound, thus protecting the skin and wound from damage. They support patient mobilisation by being comfortable, and thereby minimising painful skin damage such as blisters.
What is being measured
The primary outcome is the main question the study is designed to answer.
The proportion of participants responding "yes" to each item of the ISWCAP checklist at 6-weeks post-surgery
Measured: 6-weeks post surgery
Secondary outcomes (3)
Incidence and types of wound complications such as infection, dehiscence (as measured by the Sandy Grading System for surgical wound dehiscence classification), and blistering in the 12-weeks following surgery
Measured: From surgery until the 12-week follow-up appointment
Bluebelle Wound Healing Questionnaire, completed at Visits 5 (12-days post-surgery) and 6 (6-weeks post-surgery)
Measured: 12-days post-surgery and 6-weeks post-surgery
Dressing Comfort and Usability Survey completed at Visits 4 (7-days post-surgery) and 5 (12-days post-surgery)
Measured: 7- and 12-days post-surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Mar 2026
- Study start23 Jul 2026
- Primary completion31 Aug 2027 (estimated)
- Study completion31 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Total Hip ReplacementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Bournemouth University
- Sponsor type
- University, hospital or other
- Collaborators
- Nuffield Health Bournemouth
- Responsible party
- Principal investigator, Tom Wainwright, Bournemouth University
- Investigators
- Thomas Wainwright, Principal investigator, Bournemouth University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07471243
- Sponsor's protocol ID
- ORI/14918/25
- Acronym
- DRESS-X
- Status last verified
- Aug 2026
- First submitted
- 10 Mar 2026
- Last updated
- 24 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dressing-Related Experiences and Surgical Site Self-Care in Hip and Knee Replacement: an Observational Cohort Study (DRESS-X)
- ClinicalTrials.gov ID
- NCT07471243
- Acronym / sponsor ID
- DRESS-X / ORI/14918/25
- Conditions
- Total Hip Replacement, Total Knee Replacement
- Keywords
- Hip arthroplasty, Hip replacement, Knee arthroplasty, Knee replacement, Musculoskeletal, Enhanced recovery after surgery, ERAS, Surgical wound
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Bournemouth UniversityUniversity, hospital or other
- Collaborators
- Nuffield Health Bournemouth
- Study start
- 23 Jul 2026 (actual)
- Primary completion
- 31 Aug 2027 (estimated)
- Study completion
- 31 Aug 2027 (estimated)
- First posted
- 13 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this prospective observational cohort study is to investigate dressing-related experiences and surgical site self-care in patients who are undergoing a total hip or knee replacement. The main objectives of the study are:
- To evaluate patient adherence to the ISWCAP self-care checklist after total hip or knee replacement within an ERAS pathway.
- To explore patient-reported outcomes related to the performance and comfort of advanced dressings.
- To assess the perceived adequacy and usefulness of post-discharge wound care education.
- To identify the incidence and types of wound-related complications in the 12 weeks following surgery.
Participants will give informed consent before surgery and will start the study once the dressing has been applied following surgery. There will be follow up study visits at discharge, 7 days, 12 days, 6 weeks and 12 weeks post-surgery. Data relating to vital signs, medical history, surgery and medication will be taken from routine data.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients undergoing primary total hip or knee replacement at the Nuffield Health Hospital
Key inclusion criteria (3 listed)
- Adults (18+) undergoing primary total hip or knee replacement
- Enrolled in an ERAS protocol
- Willing and able to provide informed consent
Key exclusion criteria (3 listed)
- Requiring revision replacement
- Unable to provide informed consent (cognitive disorder such as dementia, psychiatric illness)
- Unable to understand written English
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Wound Dressing MaterialThe study will investigate any wound dressing applied as part of routine care. Advanced wound dressings are highly absorbent, flexible and comfortable for surgical wounds, and offer up to 14 days wear time. The adhesive moulds to the skin without sticking to the wound, thus protecting the skin and wound from damage. They support patient mobilisation by being comfortable, and thereby minimising painful skin damage such as blisters. | Other | – |
Primary outcome
The proportion of participants responding "yes" to each item of the ISWCAP checklist at 6-weeks post-surgery
Time frame: 6-weeks post surgery
3 secondary outcomes
Incidence and types of wound complications such as infection, dehiscence (as measured by the Sandy Grading System for surgical wound dehiscence classification), and blistering in the 12-weeks following surgery
Time frame: From surgery until the 12-week follow-up appointment
Bluebelle Wound Healing Questionnaire, completed at Visits 5 (12-days post-surgery) and 6 (6-weeks post-surgery)
Time frame: 12-days post-surgery and 6-weeks post-surgery
Dressing Comfort and Usability Survey completed at Visits 4 (7-days post-surgery) and 5 (12-days post-surgery)
Time frame: 7- and 12-days post-surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Total Hip Replacement
Not yet recruiting
Early Mobilization and Postoperative Complications in Hip Arthroplast
Arthroplasty, Replacement, Hip, Patient Education
Active, not recruitingObservational study
Bone Fixation of Mpact Double Mobility Cup
Total Hip Replacement
Recruiting
Binaural Beats for Postoperative Pain and Anxiety Reduction
TKA, THA
Recruiting
QLESP Block Versus PENG+LFCN Block for Total Hip Arthroplasty
Pain Management, Arthroplasty Total Hip Replacement
RecruitingEarly Phase 1
Evaluating the Effectiveness of Intramuscular Versus Intravenous Tranexamic Acid for Minimizing Blood Loss After Total Hip Arthroplasty: A Randomized Controlled Trial
Blood Loss After a Total Hip Replacement
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Thomas Wainwright principal investigator
Bournemouth University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Total Hip Replacement and Total Knee Replacement, run by Bournemouth University at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Tikki Immins (+441202 962727, timmins@bournemouth.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The proportion of participants responding "yes" to each item of the ISWCAP checklist at 6-weeks post-surgery (time frame: 6-weeks post surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2026; AzTrials last refreshed its copy on 7 Nov 2026.